Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advances in the Pharmacologic Management of Atrial Fibrillation.

Literature DB >> 21731596

Advances in the Pharmacologic Management of Atrial Fibrillation.

Alexander Burashnikov¹, Charles Antzelevitch.

Abstract

Entities: Chemical Disease Gene Species

Year: 2011 PMID： 21731596 PMCID： PMC3125069 DOI： 10.1016/j.ccep.2010.10.006

Source DB: PubMed Journal: Card Electrophysiol Clin ISSN： 1877-9182

Keyword Cloud
References

× No keyword cloud information.

74 in total

1. Probability of stroke: a risk profile from the Framingham Study.

Authors: P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal: Stroke Date: 1991-03 Impact factor: 7.914

2. A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutter.

Authors: Lauri Toivonen; Pekka Raatikainen; Håkan Walfridsson; Anders Englund; Finn Hegbom; Ole-Gunnar Anfinsen; Knut Gjesdal; Steen Pehrson; Susanne Johansson; Lars Frison; Anders R Berggren; Nils Edvardsson
Journal: J Cardiovasc Pharmacol Date: 2010-09 Impact factor: 3.105

3. Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.

Authors: Alexander Burashnikov; Luiz Belardinelli; Charles Antzelevitch
Journal: Heart Rhythm Date: 2010-05-15 Impact factor: 6.343

Review 4. Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium?

Authors: David Singh; Eugenio Cingolani; George A Diamond; Sanjay Kaul
Journal: J Am Coll Cardiol Date: 2010-04-13 Impact factor: 24.094

5. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation.

Authors: D R Van Wagoner; A L Pond; P M McCarthy; J S Trimmer; J M Nerbonne
Journal: Circ Res Date: 1997-06 Impact factor: 17.367

6. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors:
Journal: N Engl J Med Date: 1989-08-10 Impact factor: 91.245

Advances in the Pharmacologic Management of Atrial Fibrillation.

1. Probability of stroke: a risk profile from the Framingham Study.

2. A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutter.

3. Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.

Review 4. Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium?

5. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation.

6. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Review 7. Innovative approaches to anti-arrhythmic drug therapy.

8. Defective cardiac ryanodine receptor regulation during atrial fibrillation.

9. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Review 10. Atrial fibrillation: goals of therapy and management strategies to achieve the goals.